Animal Models Used in Hepatitis C Virus Research

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 Jun 4

PMID 32485887

Citations 18

Authors

Keith A Berggren

Saori Suzuki

Alexander Ploss

Affiliations

Soon will be listed here.

Abstract

The narrow range of species permissive to infection by hepatitis C virus (HCV) presents a unique challenge to the development of useful animal models for studying HCV, as well as host immune responses and development of chronic infection and disease. Following earlier studies in chimpanzees, several unique approaches have been pursued to develop useful animal models for research while avoiding the important ethical concerns and costs inherent in research with chimpanzees. Genetically related hepatotropic viruses that infect animals are being used as surrogates for HCV in research studies; chimeras of these surrogate viruses harboring specific regions of the HCV genome are being developed to improve their utility for vaccine testing. Concurrently, genetically humanized mice are being developed and continually advanced using human factors known to be involved in virus entry and replication. Further, xenotransplantation of human hepatocytes into mice allows for the direct study of HCV infection in human liver tissue in a small animal model. The current advances in each of these approaches are discussed in the present review.

Citing Articles

Developing T Cell Epitope-Based Vaccines Against Infection: Challenging but Worthwhile.

Tang X, Zhang W, Zhang Z Vaccines (Basel). 2025; 13(2).

PMID: 40006681 PMC: 11861332. DOI: 10.3390/vaccines13020135.

Determinants of pegivirus persistence, cross-species infection, and adaptation in the laboratory mouse.

Nennig K, Murthy S, Maloney S, Shaw T, Sharobim M, Matkovic E PLoS Pathog. 2024; 20(8):e1012436.

PMID: 39196893 PMC: 11355568. DOI: 10.1371/journal.ppat.1012436.

Understanding the relationship between HCV infection and progression of kidney disease.

Zhang M, Han Z, Lin Y, Jin Z, Zhou S, Wang S Front Microbiol. 2024; 15:1418301.

PMID: 39006752 PMC: 11239345. DOI: 10.3389/fmicb.2024.1418301.

Biomarkers in Detection of Hepatitis C Virus Infection.

Woo J, Choi Y Pathogens. 2024; 13(4).

PMID: 38668286 PMC: 11054098. DOI: 10.3390/pathogens13040331.

Pathogenesis of viral infections during pregnancy.

Creisher P, Klein S Clin Microbiol Rev. 2024; 37(2):e0007323.

PMID: 38421182 PMC: 11237665. DOI: 10.1128/cmr.00073-23.

References

Shoukry N, Grakoui A, Houghton M, Chien D, Ghrayeb J, Reimann K . Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med. 2003; 197(12):1645-55. PMC: 2193956. DOI: 10.1084/jem.20030239. View

Weatherford T, Chavez D, Brasky K, Lemon S, Martin A, Lanford R . Lack of adaptation of chimeric GB virus B/hepatitis C virus in the marmoset model: possible effects of bottleneck. J Virol. 2009; 83(16):8062-75. PMC: 2715777. DOI: 10.1128/JVI.00032-09. View

Martin A, Bodola F, Sangar D, Goettge K, Popov V, Rijnbrand R . Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA. Proc Natl Acad Sci U S A. 2003; 100(17):9962-7. PMC: 187902. DOI: 10.1073/pnas.1731505100. View

Pfaender S, Cavalleri J, Walter S, Doerrbecker J, Campana B, Brown R . Clinical course of infection and viral tissue tropism of hepatitis C virus-like nonprimate hepaciviruses in horses. Hepatology. 2014; 61(2):447-59. DOI: 10.1002/hep.27440. View

Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H . Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014; 61(1 Suppl):S45-57. DOI: 10.1016/j.jhep.2014.07.027. View

Hartlage A, Cullen J, Kapoor A . The Strange, Expanding World of Animal Hepaciviruses. Annu Rev Virol. 2016; 3(1):53-75. PMC: 5523456. DOI: 10.1146/annurev-virology-100114-055104. View

Shultz L, Brehm M, Garcia-Martinez J, Greiner D . Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol. 2012; 12(11):786-98. PMC: 3749872. DOI: 10.1038/nri3311. View

Pfaender S, Brown R, Pietschmann T, Steinmann E . Natural reservoirs for homologs of hepatitis C virus. Emerg Microbes Infect. 2015; 3(3):e21. PMC: 3974340. DOI: 10.1038/emi.2014.19. View

Warter L, Cohen L, Benureau Y, Chavez D, Yang Y, Bodola F . A cooperative interaction between nontranslated RNA sequences and NS5A protein promotes in vivo fitness of a chimeric hepatitis C/GB virus B. PLoS One. 2009; 4(2):e4419. PMC: 2635954. DOI: 10.1371/journal.pone.0004419. View

10.

Bartosch B, Bukh J, Meunier J, Granier C, Engle R, Blackwelder W . In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci U S A. 2003; 100(24):14199-204. PMC: 283569. DOI: 10.1073/pnas.2335981100. View

11.

Griffin S, Trowbridge R, Thommes P, Parry N, Rowlands D, Harris M . Chimeric GB virus B genomes containing hepatitis C virus p7 are infectious in vivo. J Hepatol. 2008; 49(6):908-15. PMC: 3098382. DOI: 10.1016/j.jhep.2008.07.020. View

12.

Yanagi M, Purcell R, Emerson S, Bukh J . Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci U S A. 1997; 94(16):8738-43. PMC: 23104. DOI: 10.1073/pnas.94.16.8738. View

13.

Forns X, Bukh J, Purcell R . The challenge of developing a vaccine against hepatitis C virus. J Hepatol. 2002; 37(5):684-95. DOI: 10.1016/s0168-8278(02)00308-2. View

14.

Sayed I, Verhoye L, Cocquerel L, Abravanel F, Foquet L, Montpellier C . Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver. Gut. 2016; 66(5):920-929. DOI: 10.1136/gutjnl-2015-311109. View

15.

Sithebe N, Kew M, Mphahlele M, Paterson A, Lecatsas G, Kramvis A . Lack of susceptibility of Chacma baboons (Papio ursinus orientalis) to hepatitis C virus infection. J Med Virol. 2002; 66(4):468-71. DOI: 10.1002/jmv.2167. View

16.

Hartlage A, Walker C, Kapoor A . Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus. J Virol. 2020; 94(10). PMC: 7199419. DOI: 10.1128/JVI.00035-20. View

17.

Woollard D, Haqshenas G, Dong X, Pratt B, Kent S, Gowans E . Virus-specific T-cell immunity correlates with control of GB virus B infection in marmosets. J Virol. 2007; 82(6):3054-60. PMC: 2259009. DOI: 10.1128/JVI.01153-07. View

18.

Flint M, von Hahn T, Zhang J, Farquhar M, Jones C, Balfe P . Diverse CD81 proteins support hepatitis C virus infection. J Virol. 2006; 80(22):11331-42. PMC: 1642177. DOI: 10.1128/JVI.00104-06. View

19.

Tesfaye A, Stift J, Maric D, Cui Q, Dienes H, Feinstone S . Chimeric mouse model for the infection of hepatitis B and C viruses. PLoS One. 2013; 8(10):e77298. PMC: 3796464. DOI: 10.1371/journal.pone.0077298. View

20.

Barnes E, Folgori A, Capone S, Swadling L, Aston S, Kurioka A . Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man. Sci Transl Med. 2012; 4(115):115ra1. PMC: 3627207. DOI: 10.1126/scitranslmed.3003155. View